Articles By RheumNow
FDA Review: Take Two for Baricitinib
By RheumNow
FDA staff remain worried about the safety of baricitinib, an oral JAK inhibitor intended for treatment of rheumatoid arthritis, according to briefing documents prepared for an advisory committee meeting on Monday.
Read Article
Apremilast in DMARD-Naive Psoriatic Arthritis
By RheumNow
Apremilast (Otezla) monotherapy was effective for psoriatic arthritis among patients who had not previously received disease-modifying anti-rheumatic drugs (DMARDs) or biologics, a phase III clinical trial funded by the drug's manufacturer found.
Read Article
Uveitis in JIA: Screen All, Treat Early
By RheumNow
A European group of experts has formulated consensus-based recommendations for the treatment of juvenile idiopathic arthritis (JIA)-associated uveitis, focusing on screening, monitoring, and treatment of this potentially devastating extra-articular manifestation of JIA.
Read Article
Obesity Surgery Tames Knee OA Pain
By RheumNow
Laparoscopic gastric band (LAGB) surgery was associated with significant decreases in knee pain from osteoarthritis (OA), with the greatest improvements seen among those whose body mass index (BMI) had the greatest decreases and among younger patients, researchers reported.
Read Article
2 Weeks Off Methotrexate OK for Flu Vaccine
By RheumNow
Stopping methotrexate for 2 weeks after the administration of flu vaccine led to improved immunogenicity without increasing disease activity among patients with rheumatoid arthritis (RA), a prospective Korean study showed.
Read Article
Tai Chi Eases Fibromyalgia Pain
By RheumNow
The mind-body practice of tai chi was as effective or better than currently recommended aerobic exercise for fibromyalgia, a randomized controlled trial demonstrated.
Read Article
Novel Approach to Knee Osteoarthritis Pain
By RheumNow
Geniculate artery embolization was found to dampen knee pain arising from osteoarthritis, according to interim study results presented at the 2018 annual meeting of the Society of Interventional Radiology.
Read Article
Does Dose Escalation Help in Gout?
By RheumNow
Contrary to expectations, dose escalation of allopurinol among patients with gout did not improve survival, a 10-year observational study found.
Read Article
Biologics in Pregnancy: Are They Safe?
By RheumNow
Exposure to biologic therapies among women with autoimmune diseases was not associated with increased risks of preterm delivery or having small for gestational age babies, a population-based Canadian study found.
Read Article
Shorter Steroid Courses Effective in ANCA+ Vasculitis
By RheumNow
An 8-week course of prednisone plus rituximab (Rituxin) offered good outcomes in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), including complete remission, researchers reported.
Read Article